Christoph Schweizer is chairman of Central and Eastern Europe and the Middle East at Boston Consulting Group, covering 39 offices in 23 countries. He has also been a member of the firm's Executive and Operating Committees since 2014. In May 2021, Christoph was elected to be the next CEO of BCG starting October 1.

Christoph joined BCG in 1997, first in Munich, and then New York from 2007 to 2012, before returning to Munich. Prior to his current role, he served as chair of BCG’s global practices and oversaw the firm’s large-scale change initiatives: transformation, enablement, and post-merger integration. He was previously global leader of the Health Care practice.

Christoph has supported clients in healthcare, private equity, and across industries in major transformational programs such as digital transformations and post-merger integrations. He is a passionate supporter of a wide range of social impact activities, in particular related to sustainability and fighting climate change.

AREAS OF EXPERTISE

EDUCATION

  • MBA, University of Texas at Austin
  • BA, WHU Koblenz

Publications and Videos

As-Vaccines-Roll-Out-Testing-Still-Matters-rectangle.jpg

As Vaccines Roll Out, Testing Still Matters

Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.
new-globalization-rhetoric-overlay-2880x1620-tcm9-155486.jpg

Going Beyond the Rhetoric

Globalization isn’t dying; it’s changing. Companies that base their strategies on an outdated narrative risk missing some of the world’s biggest growth opportunities.
medtech-emerging-markets-1694x950-tcm9-146672.jpg

Medtech May Be Emerging Markets’ Next New Thing

Medtech has been a late bloomer in emerging markets, but as demand for health care in these regions increases, local medtech companies are positioned for success.
competing-on-outcomes-1694x950-tcm9-60077.jpg

Competing on Outcomes: Winning Strategies for Value-Based Health Care

A new focus on value is fundamentally changing the terms of competition in the health care market. The winners will be organizations that compete on outcomes.
bcg-publication-4.jpg

Qualitätswettbewerb: Chancen für Deutschlands Gesundheitssystem

Deutschland hat ein international sehr anerkanntes Gesundheitssystem. Wir stehen dennoch vor zwei großen Herausforderungen.
Tiefgreifende Expertise, umfassende Erfahrung